Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular and cellular paradigms of multidrug resistance in cancer
Foram U. Vaidya, Abu Sufiyan Chhipa, Vinita Mishra, et al.
Cancer Reports (2020) Vol. 5, Iss. 12
Open Access | Times Cited: 157

Showing 26-50 of 157 citing articles:

Molecular Basis of Resveratrol-Induced Resensitization of Acquired Drug-Resistant Cancer Cells
Chul Yung Choi, Sung‐Chul Lim, Tae-Bum Lee, et al.
Nutrients (2022) Vol. 14, Iss. 3, pp. 699-699
Open Access | Times Cited: 25
The current status and future prospects for therapeutic targeting of KEAP1-NRF2 and β-TrCP-NRF2 interactions in cancer chemoresistance
Rohini Srivastava, Raquel Fernández-Ginés, José Antonio Encinar, et al.
Free Radical Biology and Medicine (2022) Vol. 192, pp. 246-260
Open Access | Times Cited: 23
Novel betulin derivatives as multidrug reversal agents targeting P-glycoprotein
Jerónimo Laiolo, Dafni G. Graikioti, Cecilia L. Barbieri, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Recent advances in molecular targeted therapy of lung cancer: Possible application in translation medicine.
Elnaz Salmani-Javan, Mahdi Farhoudi Sefidan Jadid, Nosratollah Zarghami
PubMed (2024) Vol. 27, Iss. 2, pp. 122-133
Closed Access | Times Cited: 5
Drug resistance in human cancers — Mechanisms and implications
Sudikshaa Vijayakumar, Raveena Dhakshanamoorthy, Akshaya Baskaran, et al.
Life Sciences (2024) Vol. 352, pp. 122907-122907
Closed Access | Times Cited: 5
Hydrazide-Based Class I Selective HDAC Inhibitors Completely Reverse Chemoresistance Synergistically in Platinum-Resistant Solid Cancer Cells
Fabian B. Kraft, Lukas Biermann, Linda Schäker‐Hübner, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 19, pp. 17796-17819
Closed Access | Times Cited: 5
Elucidating the binding specificity of interactive compounds targeting ATP-binding cassette subfamily G member 2 (ABCG2)
Pawan Kumar, Indu Kumari, Rajendra Prasad, et al.
Molecular Diversity (2025)
Open Access
Investigating the role of exosomal long non-coding RNAs in drug resistance within female reproductive system cancers
Nooshafarin Shirani, N. Abdi, Matin Chehelgerdi, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access
Differences in treatment outcome between translational platforms in developing therapies for gastrointestinal cancers.
Katarzyna Wawrzak-Pienkowska, Tomasz Pienkowski, Anna Tankiewicz‐Kwedlo, et al.
European Journal of Pharmacology (2025), pp. 177309-177309
Closed Access
Phytoconstituents as emerging therapeutics for breast cancer: Mechanistic insights and clinical implications
Mahalakshmi Devaraji, Punniyakoti T. Veeraveedu
Cancer Pathogenesis and Therapy (2025)
Open Access
Advanced materials for cancer treatment and beyond
Lei Zhang, Yanan Wang, Yang‐Jia Li, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Salidroside Promotes Sensitization to Doxorubicin in Human Cancer Cells by Affecting the PI3K/Akt/HIF Signal Pathway and Inhibiting the Expression of Tumor-Resistance-Related Proteins
Qi Zeng, Xu Nie, Li Li, et al.
Journal of Natural Products (2022) Vol. 85, Iss. 1, pp. 196-204
Closed Access | Times Cited: 20
Advances in Hydrogel-Based Microfluidic Blood–Brain-Barrier Models in Oncology Research
Ankur Sood, Anuj Kumar, Atul Dev, et al.
Pharmaceutics (2022) Vol. 14, Iss. 5, pp. 993-993
Open Access | Times Cited: 20
Insights on the Role of Polyphenols in Combating Cancer Drug Resistance
Mohd Farhan
Biomedicines (2023) Vol. 11, Iss. 6, pp. 1709-1709
Open Access | Times Cited: 12
Nanoparticle-Based Antioxidants in Stress Signaling and Programmed Cell Death in Breast Cancer Treatment
Yedi Herdiana, Sriwidodo Sriwidodo, Ferry Ferdiansyah Sofian, et al.
Molecules (2023) Vol. 28, Iss. 14, pp. 5305-5305
Open Access | Times Cited: 12
Drug resistance mechanisms in cancers: Execution of pro-survival strategies
Pavan Kumar Dhanyamraju
Journal of Biomedical Research (2023) Vol. 38, Iss. 2, pp. 95-95
Open Access | Times Cited: 11
Deciphering cellular and molecular mechanism of MUC13 mucin involved in cancer cell plasticity and drug resistance
Shabnam Malik, Mohammed Sikander, Mohd Wahid, et al.
Cancer and Metastasis Reviews (2024)
Closed Access | Times Cited: 4
Increased V-ATPase activity can lead to chemo-resistance in oral squamous cell carcinoma via autophagy induction: new insights
Ahmadreza Lagzian, Marziye Askari, Melika Sadat Haeri, et al.
Medical Oncology (2024) Vol. 41, Iss. 5
Closed Access | Times Cited: 4
Biomarkers, isolation methods, and therapeutic implications of breast cancer stem cells
Peik Lin Teoh, Neha Saini
Cancer Pathogenesis and Therapy (2025)
Open Access
Multidrug-resistant osteosarcoma: A systematic review
Mokhtar Ahmed Alsayed, Raad M. M. Althaqafi, Hashem Bukhary, et al.
Journal of Clinical Sciences (2025) Vol. 22, Iss. 1, pp. 42-50
Open Access
An Overview of Cellular and Molecular Determinants Regulating Chemoresistance in Pleural Mesothelioma
Lourdes Cortes‐Dericks, Domenico Galetta
Cancers (2025) Vol. 17, Iss. 6, pp. 979-979
Open Access
Oral Bioavailability Enhancement of Anti-Cancer Drugs Through Lipid Polymer Hybrid Nanoparticles
Saud Almawash
Pharmaceutics (2025) Vol. 17, Iss. 3, pp. 381-381
Open Access
Biomimetic Nanoparticles: A Revolutionary Approach to Breast Cancer Therapy Using Cell Membrane Coatings
Jyoti Chandra, Nagashekhara Molugulu, Garima Gupta, et al.
Journal of Drug Delivery Science and Technology (2025), pp. 106849-106849
Closed Access
Differentially expressed and alternately spliced genes as a novel tool for genotoxicity: a computerized study in ATT-myc transgenic mice for the recognition of genotoxic and non-genotoxic chemical
Mansour A. Alghamdi, Eman Mohamad El Nashar, Mahmoud Elalfy, et al.
Frontiers in Genetics (2025) Vol. 16
Open Access
Synergizing tyrosine kinase inhibitors with structurally diverse natural products: strategies to enhance efficacy and overcome drug resistance in liver cancer
Jiawen Chen, Sibao Chen, Guoqing Chen
Deleted Journal (2025) Vol. 2, Iss. 1
Open Access

Scroll to top